Segment Information (Tables)

3 Months Ended

Mar. 31, 2017

Segment Reconciliation [Abstract]

Reconciliation of Revenue from Segments to Consolidated

The tables below present information about our reportable segments (in thousands):

	Three Months Ended
	March 31, 2017		April 1, 2016
Segment sales by product line:
Medical
Cardio & Vascular	$	125,108	$	113,671
Cardiac & Neuromodulation	103,813		108,533
Advanced Surgical, Orthopedics & Portable Medical	105,146		98,362
Total Medical	$	334,067	$	320,566
Non-Medical	11,346		11,672
Total sales	$	345,413	$	332,238

Reconciliation of Operating Profit (Loss) from Segments to Consolidated

	Three Months Ended
	March 31, 2017			April 1, 2016
Segment income (loss) from operations:
Medical	$	50,360		$	31,841
Non-Medical	1,562			(1,011		)
Total segment income from operations	51,922			30,830
Unallocated operating expenses	(25,377		)	(19,696		)
Operating income	26,545			11,134
Unallocated expenses, net	(30,740		)	(23,896		)
Loss before provision (benefit) for income taxes	$	(4,195	)	$	(12,762	)